ETFs Sanofi

Equities

SAN

FR0000120578

Pharmaceuticals

Market Closed - Euronext Paris 16:35:21 12/07/2024 BST 5-day change 1st Jan Change
94.4 EUR +0.63% Intraday chart for Sanofi +3.80% +5.17%

ETFs positioned on Sanofi

Name Weight AuM 1st Jan change Investor Rating
6.31% 5 M€ +4.56%
3.66% 134 M€ -.--% -
3.55% 264 M€ +13.50% -
3.30% 21 M€ +11.32% -
2.51% 7 M€ +8.64% -
2.30% 754 M€ +6.48%
2.20% 2 M€ -25.75%
1.96% 2 M€ +9.05%
1.94% 3 M€ +9.95% -
1.44% 6 M€ -.--% -
1.16% 251 M€ +8.96%
0.99% 6 M€ -.--%
0.98% 51 M€ +8.71%
0.82% 35 M€ +8.73% -
0.80% 1,056 M€ +4.47%
0.67% 10 M€ -3.35% -
0.59% 5 M€ -.--% -
0.54% 29 M€ +8.37% -
0.53% 2 M€ -.--% -
0.53% 2 M€ +9.19% -
0.42% 7 M€ +8.00% -
0.41% 749 M€ +11.69%
0.36% 205 M€ -.--%
0.30% 284 M€ -.--%
Sanofi is the largest European pharmaceutical group. Net sales by family of products break down as follows: - pharmaceutical products (70.6%): prescription drugs in the areas of specialty medicine (59.3% of net sales; for the treatment of multiple sclerosis, neurological diseases, inflammatory diseases, autoimmune diseases, rare diseases, cancers and rare hematological diseases) and general medicine (40.7%; mainly for the treatment of diabetes and cardiovascular diseases); - human vaccines (17.4%): pediatric vaccines, vaccines for flu, meningitis, and polio, booster vaccines, and vaccines for travelers and endemic areas; - consumer health products (12%). At the end of 2023, the group had 54 production sites throughout the world. Net sales are distributed geographically as follows: France (5.5%), Europe (18.6%), the United States (43%), North America (1.6%) and other (31.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
22
Last Close Price
94.4 EUR
Average target price
108.8 EUR
Spread / Average Target
+15.27%
Consensus